276 related articles for article (PubMed ID: 21047921)
1. Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion.
Martinelli CE; Keogh JM; Greenfield JR; Henning E; van der Klaauw AA; Blackwood A; O'Rahilly S; Roelfsema F; Camacho-Hübner C; Pijl H; Farooqi IS
J Clin Endocrinol Metab; 2011 Jan; 96(1):E181-8. PubMed ID: 21047921
[TBL] [Abstract][Full Text] [Related]
2. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
Aimaretti G; Colao A; Corneli G; Pivonello R; MacCario M; Morrison K; Pflaum CD; Strasburger CJ; Lombardi G; Ghigo E
Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
[TBL] [Abstract][Full Text] [Related]
3. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
4. Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone.
Tan HY; Steyn FJ; Huang L; Cowley M; Veldhuis JD; Chen C
J Physiol; 2016 Dec; 594(24):7309-7326. PubMed ID: 27558671
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
Ballerini MG; Ropelato MG; Domené HM; Pennisi P; Heinrich JJ; Jasper HG
J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children.
Saitoh H; Kamoda T; Nakahara S; Hirano T; Nakamura N
Clin Endocrinol (Oxf); 1998 Apr; 48(4):487-92. PubMed ID: 9640416
[TBL] [Abstract][Full Text] [Related]
8. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
[TBL] [Abstract][Full Text] [Related]
9. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
Benbassat CA; Maki KC; Unterman TG
J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
[TBL] [Abstract][Full Text] [Related]
12. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency.
Yuen KC; Cook DM; Rumbaugh EE; Cook MB; Dunger DB
Horm Res; 2006; 65(1):6-13. PubMed ID: 16340214
[TBL] [Abstract][Full Text] [Related]
13. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
[TBL] [Abstract][Full Text] [Related]
14. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
[TBL] [Abstract][Full Text] [Related]
15. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
[TBL] [Abstract][Full Text] [Related]
16. Continuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: a randomized sham-controlled study.
Hoyos CM; Killick R; Keenan DM; Baxter RC; Veldhuis JD; Liu PY
Sleep; 2014 Apr; 37(4):733-41. PubMed ID: 24899762
[TBL] [Abstract][Full Text] [Related]
17. Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children.
Garrone S; Radetti G; Sidoti M; Bozzola M; Minuto F; Barreca A
J Clin Endocrinol Metab; 2002 Dec; 87(12):5455-60. PubMed ID: 12466336
[TBL] [Abstract][Full Text] [Related]
18. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
19. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO
Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742
[TBL] [Abstract][Full Text] [Related]
20. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
Attia N; Tamborlane WV; Heptulla R; Maggs D; Grozman A; Sherwin RS; Caprio S
J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
